1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Cancer Drug News 31 AUGUST 2015

Cancer Drug News 31 AUGUST 2015

  • September 2015
  • -
  • Espicom Business Intelligence
  • -
  • 8 pages

Industry Trend Analysis - Heightened Market Activity Will Dampen Late BRAF/MEK Entry Performance
Industry Trend Analysis - Current Ultra-Orphan Disease Investment Will Secure Long-Term Revenue Streams
Industry Brief - Onconova Files European Application For Global Phase III Rigosertib Trial
Industry Brief - Merus Raises Funds To Advance Immunotherapeutic Pipeline
Industry Brief - Ono Seeks Carfilzomib Approval In Japan For r/r MM
Industry Trend Analysis - Autoimmune Success Will Be Key To Reversing Arzerra's Fortunes
Industry Brief - Oncolytics Completes Enrolment In Reolysin Phase II NSCLC Study
Industry Brief - BI's Afatinib Applications Accepted By FDA/EMA
Industry Brief - Tocagen's Candidates Gains FDA ODD For Glioblastoma
Industry Brief - Advaxis Inks Deal With Knight Therapeutics/Raises Funds
Industry Brief - Court Rules In Favour Of Lilly In Alimta Patent Challenge
Industry Brief - MorphoSys/Immatics Enter Immuno-oncology Collaboration

Table Of Contents

Cancer Drug News 31 AUGUST 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.